(Q40398984)

20 September 2017

Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury (English)

1 reference

20 September 2017

Steven de Maat

14

0 references

Malgorzata Wygrecka

Malgorzata Wygrecka

1

0 references

Grażyna Kwapiszewska

Grazyna Kwapiszewska

8

0 references

Leigh M Marsh

Leigh M Marsh

9

0 references

Coen Maas

Coen Maas

15

0 references

Liliana Schaefer

Liliana Schaefer

21

0 references

Ralph T Schermuly

Ralph T Schermuly

18

0 references

Werner Seeger

Werner Seeger

19

0 references

Katrin Reppe

4

Katrin Reppe

1 reference

20 September 2017

20

Martin Witzenrath

1 reference

20 September 2017

7

Miroslava Didiasova

1 reference

20 September 2017

2

Djuro Kosanovic

1 reference

20 September 2017

12

Dariusz Zakrzewicz

1 reference

20 September 2017

22

Philipp Markart

1 reference

20 September 2017

10

Nelli Baal

1 reference

20 September 2017

5

Ingrid Henneke

1 reference

20 September 2017

Lukasz Wujak

3

1 reference

20 September 2017

Helena Frey

6

1 reference

20 September 2017

Holger Hackstein

11

1 reference

20 September 2017

Holger C Müller-Redetzky

13

1 reference

20 September 2017

Marc W Nolte

16

1 reference

20 September 2017

Con Panousis

17

1 reference

20 September 2017

language of work or name

English

0 references

publication date

22 December 2016

1 reference

American Journal of Respiratory and Critical Care Medicine

20 September 2017

1 reference

20 September 2017

196

1 reference

20 September 2017

2

1 reference

20 September 2017

186-199

1 reference

Acute respiratory distress syndrome: the Berlin Definition

20 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Update in Critical Care 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Acute respiratory distress syndrome: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Circulating histones are mediators of trauma-associated lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Anticoagulants for acute respiratory distress syndrome: can they work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Contact system revisited: an interface between inflammation, coagulation, and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Animal models of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Action of heparin on protein fractions of isolated nuclei and on their DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Extracellular histones are major mediators of death in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Extracellular chromatin is an important mediator of ischemic stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Release and activity of histone in diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

A direct role for C1 inhibitor in regulation of leukocyte adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

The structural basis for neutrophil inactivation of C1 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Human CRP defends against the toxicity of circulating histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

C1 inhibitor, a multi-functional serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201604-0712OC

10.1164/RCCM.201604-0712OC

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference